ALDX
Price
$5.70
Change
+$0.14 (+2.52%)
Updated
Sep 8, 04:59 PM (EDT)
Capitalization
333.85M
66 days until earnings call
CMVLF
Price
$2.60
Change
-$0.52 (-16.67%)
Updated
Sep 2 closing price
Capitalization
267.21M
Interact to see
Advertisement

ALDX vs CMVLF

Header iconALDX vs CMVLF Comparison
Open Charts ALDX vs CMVLFBanner chart's image
Aldeyra Therapeutics
Price$5.70
Change+$0.14 (+2.52%)
Volume$6.47K
Capitalization333.85M
Cellectis Romainville
Price$2.60
Change-$0.52 (-16.67%)
Volume$160
Capitalization267.21M
ALDX vs CMVLF Comparison Chart in %
Loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMVLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALDX vs. CMVLF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a Hold and CMVLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (ALDX: $5.56 vs. CMVLF: $2.60)
Brand notoriety: ALDX and CMVLF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 104% vs. CMVLF: 72%
Market capitalization -- ALDX: $333.85M vs. CMVLF: $267.21M
ALDX [@Biotechnology] is valued at $333.85M. CMVLF’s [@Biotechnology] market capitalization is $267.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 0 FA rating(s) are green whileCMVLF’s FA Score has 1 green FA rating(s).

  • ALDX’s FA Score: 0 green, 5 red.
  • CMVLF’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALDX and CMVLF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 4 TA indicator(s) are bullish while CMVLF’s TA Score has 3 bullish TA indicator(s).

  • ALDX’s TA Score: 4 bullish, 5 bearish.
  • CMVLF’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, CMVLF is a better buy in the short-term than ALDX.

Price Growth

ALDX (@Biotechnology) experienced а -4.79% price change this week, while CMVLF (@Biotechnology) price change was -16.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.13%. For the same industry, the average monthly price growth was +10.99%, and the average quarterly price growth was +33.00%.

Reported Earning Dates

ALDX is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (+2.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALDX($334M) has a higher market cap than CMVLF($267M). CMVLF YTD gains are higher at: 73.333 vs. ALDX (11.423). CMVLF has higher annual earnings (EBITDA): -30.25M vs. ALDX (-48.46M). CMVLF has more cash in the bank: 196M vs. ALDX (81.9M). ALDX has less debt than CMVLF: ALDX (15.6M) vs CMVLF (94.8M). CMVLF has higher revenues than ALDX: CMVLF (56.3M) vs ALDX (0).
ALDXCMVLFALDX / CMVLF
Capitalization334M267M125%
EBITDA-48.46M-30.25M160%
Gain YTD11.42373.33316%
P/E RatioN/AN/A-
Revenue056.3M-
Total Cash81.9M196M42%
Total Debt15.6M94.8M16%
FUNDAMENTALS RATINGS
ALDX vs CMVLF: Fundamental Ratings
ALDX
CMVLF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
29
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
4038
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CMVLF's Valuation (29) in the null industry is in the same range as ALDX (48) in the Biotechnology industry. This means that CMVLF’s stock grew similarly to ALDX’s over the last 12 months.

CMVLF's Profit vs Risk Rating (100) in the null industry is in the same range as ALDX (100) in the Biotechnology industry. This means that CMVLF’s stock grew similarly to ALDX’s over the last 12 months.

CMVLF's SMR Rating (98) in the null industry is in the same range as ALDX (98) in the Biotechnology industry. This means that CMVLF’s stock grew similarly to ALDX’s over the last 12 months.

CMVLF's Price Growth Rating (38) in the null industry is in the same range as ALDX (40) in the Biotechnology industry. This means that CMVLF’s stock grew similarly to ALDX’s over the last 12 months.

CMVLF's P/E Growth Rating (100) in the null industry is in the same range as ALDX (100) in the Biotechnology industry. This means that CMVLF’s stock grew similarly to ALDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALDXCMVLF
RSI
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
50%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
35%
Momentum
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
70%
MACD
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
48%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
60%
Advances
ODDS (%)
Bullish Trend 19 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
79%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
75%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
39%
View a ticker or compare two or three
Interact to see
Advertisement
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMVLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TGOLF0.040.01
+17.92%
Thunder Gold Corp.
NCAUF0.470.03
+6.87%
Newcore Gold Ltd.
AAGIY37.130.01
+0.03%
AIA Group, Ltd.
KNFSF1.32N/A
N/A
Kiatnakin Phatra Bank Public Company Ltd.
AKBTY2.80-0.05
-1.75%
Akbank Turk Anonim Sirketi

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with GSGTF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then GSGTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
+0.54%
GSGTF - ALDX
56%
Loosely correlated
N/A
PLRX - ALDX
38%
Loosely correlated
+14.11%
ARVN - ALDX
37%
Loosely correlated
+2.89%
CGON - ALDX
35%
Loosely correlated
+6.88%
MGTX - ALDX
32%
Poorly correlated
-0.39%
More

CMVLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMVLF has been loosely correlated with TENX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CMVLF jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMVLF
1D Price
Change %
CMVLF100%
N/A
TENX - CMVLF
56%
Loosely correlated
-0.08%
SBHMY - CMVLF
51%
Loosely correlated
N/A
AURA - CMVLF
30%
Poorly correlated
+0.93%
ALDX - CMVLF
23%
Poorly correlated
+0.54%
TARS - CMVLF
23%
Poorly correlated
+0.35%
More